Review of Clinical Pharmacology and Pharmacokinetics – International Edition became in September 2023 an open access journal.
Review of Clinical Pharmacology and Pharmacokinetics – International Edition is an open access Journal which publishes articles as Gold Open Access distributed under the terms and conditions of the Creative Commons Attribution License (CC BY).
The copyright is retained by the author. PHARMAKON- Press will insert the following note in the published text:
© 2024 by the authors; licensee PHARMAKON- Press, Athens, Greece. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution License.
Authors Open Access Benefits
Authors can have free accessibility and visibility of all the full text articles published with PHARMAKON- Press. Readers of open access journal do not need to pay any subscription to read articles published by PHARMAKON- Press.
Open access publishing makes it possible for scholars, policy makers, practitioners, clinicians, and the general public to be able to view, cite, and share the published articles.
The open access articles results to the Higher Citation Impact from their high publicity and availability. Open access publications are more frequently cited.
High Visibility: abstracted and indexed within Scopus, Chemical Abstracts, SCImago Journal and Country Rank Factor, ResearchGate, Google Scholar and CrossRef.
Rapid Publication in PHARMAKON- Press: articles are reviewed by the members of our scientific committee -Editorial Board. A first decision is provided to authors approximately in a week after submission. Acceptance for publication is approximately in a month. Faster Publication in PHARMAKON- Press’s open access journal is achieved by online availability.